Citigroup’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6K | Sell |
2,166
-2,173
| -50% | -$19.7K | ﹤0.01% | 4351 |
|
|
2025
Q1 | $41.4K | Sell |
4,339
-540
| -11% | -$5.15K | ﹤0.01% | 4162 |
|
|
2024
Q4 | $54.8K | Buy |
4,879
+571
| +13% | +$6.41K | ﹤0.01% | 4217 |
|
|
2024
Q3 | $61.9K | Buy |
4,308
+3,009
| +232% | +$43.2K | ﹤0.01% | 4181 |
|
|
2024
Q2 | $22.4K | Sell |
1,299
-6,958
| -84% | -$120K | ﹤0.01% | 4235 |
|
|
2024
Q1 | $165K | Sell |
8,257
-1,267
| -13% | -$25.3K | ﹤0.01% | 3371 |
|
|
2023
Q4 | $100K | Buy |
+9,524
| New | +$100K | ﹤0.01% | 3456 |
|
|
2023
Q2 | – | Sell |
-12,498
| Closed | -$172K | – | 4828 |
|
|
2023
Q1 | $172K | Buy |
+12,498
| New | +$172K | ﹤0.01% | 3186 |
|
|
2022
Q3 | – | Sell |
-34
| Closed | – | – | 5128 |
|
|
2022
Q2 | $0 | Sell |
34
-115
| -77% | – | ﹤0.01% | 5505 |
|
|
2022
Q1 | $3K | Sell |
149
-884
| -86% | -$17.8K | ﹤0.01% | 5134 |
|
|
2021
Q4 | $25K | Sell |
1,033
-605
| -37% | -$14.6K | ﹤0.01% | 4561 |
|
|
2021
Q3 | $64K | Buy |
1,638
+27
| +2% | +$1.06K | ﹤0.01% | 3866 |
|
|
2021
Q2 | $72K | Buy |
1,611
+1,096
| +213% | +$49K | ﹤0.01% | 3978 |
|
|
2021
Q1 | $18K | Buy |
+515
| New | +$18K | ﹤0.01% | 4647 |
|